TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - SANOFI Share Price

Certificat

DE000CL5WYF4

Delayed Deutsche Boerse AG 12:47:56 20/05/2024 pm IST
2 EUR +0.50% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - SANOFI
Current month-2.93%
1 month+36.30%
Date Price Change
20/24/20 2 +0.50%
17/24/17 1.99 -3.40%
16/24/16 2.06 -1.44%
15/24/15 2.09 -6.28%
14/24/14 2.23 -5.51%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 12:47 pm IST

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Société Générale Société Générale
WKN CL5WYF
ISINDE000CL5WYF4
Date issued 18/03/2020
Strike 69.71
Maturity Unlimited
Parity 10 : 1
Emission price 1
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.85
Lowest since issue 0.24
Spread 0.01
Spread %0.50%

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
89.17 EUR
Average target price
108.3 EUR
Spread / Average Target
+21.49%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW